YOLFTbeta
SciVision Biotech Inc

SciVision Biotech Inc

1786 · TW · Healthcare / Medical Instruments & Supplies

50.60TWD+1.50 (+3.05%)

Price History

Full chart

Market Stats

Previous Close49.10
Open50.00
Day Range49.55 – 51.90
52-Week Range42.25 – 111.00
Volume659.79K
Market Cap3.11B
P/E (TTM)17.91
Forward P/E0.00
EPS2.39
Dividend Yield4.41%
Beta0.46
50-Day Avg47.11
200-Day Avg60.03

About

SciVision Biotech Inc. develops and manufactures medical-grade hyaluronic acid products in Taiwan. The company offers synovial fluid supplements, facial dermal implants, absorbable adhesion barriers, and intravesical instillation products. It also involved in international trade; wholesale of medical equipment and cosmetics; and provides management advisory services. SciVision Biotech Inc. was founded in 1990 and is based in Kaohsiung, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Tai Xian Han
  • Employees0
  • HeadquartersNo. 1, South 1st Road, Kaohsiung, Taiwan, 806, Taiwan
  • Websitehttps://www.scivision.com.tw

Leadership

  • Mr. Tai Xian HanGeneral Manager
  • Ms. Ru Ling GuoDeputy GM, VP, Financial Officer & Accounting Officer and Director

Financials

Income Statement

Currency: TWD2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue15.68M66.22M143.27M200.68M200.51M158.28M264.84M228.30M258.42M329.58M437.87M466.88M505.54M557.35M712.99M883.31M886.62M
Growth (%)-+322.24%+116.37%+40.07%-0.09%-21.06%+67.32%-13.80%+13.19%+27.54%+32.86%+6.62%+8.28%+10.25%+27.93%+23.89%+0.37%
Cost of Revenue28.10M43.12M52.37M77.50M84.81M78.80M109.27M101.15M105.59M112.66M132.42M123.60M163.70M185.48M200.49M227.63M248.23M
Gross Profit-12.42M23.09M90.90M123.18M115.70M79.49M155.58M127.16M152.83M216.92M305.46M343.28M341.84M371.87M512.49M655.68M638.39M
Gross Margin-79.20%34.87%63.45%61.38%57.70%50.22%58.74%55.70%59.14%65.82%69.76%73.53%67.62%66.72%71.88%74.23%72.00%
Operating Expense38.54M35.72M47.44M72.53M84.31M101.61M108.57M153.15M125.97M136.26M164.78M181.38M217.59M195.64M312.86M407.57M448.47M
Operating Income-50.96M-12.63M43.47M50.65M31.39M-22.13M47.01M-25.99M26.86M80.66M140.68M161.90M124.25M176.23M199.64M248.11M189.92M
Operating Margin-324.95%-19.07%30.34%25.24%15.66%-13.98%17.75%-11.39%10.39%24.47%32.13%34.68%24.58%31.62%28.00%28.09%21.42%
EBITDA-31.22M8.65M66.44M73.25M54.11M-2.99M66.85M-4.76M47.80M116.42M155.18M177.21M177.27M238.28M281.35M362.50M270.35M
EBITDA Margin-199.08%13.07%46.37%36.50%26.98%-1.89%25.24%-2.09%18.50%35.32%35.44%37.96%35.07%42.75%39.46%41.04%30.49%
Net Income-52.53M-6.86M51.16M62.43M40.35M-22.14M54.84M-26.26M17.14M86.87M120.70M128.00M101.72M141.72M177.90M242.25M162.34M
Net Income Margin-335.00%-10.37%35.71%31.11%20.12%-13.99%20.71%-11.50%6.63%26.36%27.57%27.42%20.12%25.43%24.95%27.43%18.31%
R&D21.13M20.03M17.73M26.94M26.41M37.24M24.86M30.50M39.25M47.98M43.25M59.77M65.94M52.46M53.41M60.71M93.19M
R&D as % of Total Revenue134.77%30.26%12.38%13.42%13.17%23.53%9.39%13.36%15.19%14.56%9.88%12.80%13.04%9.41%7.49%6.87%10.51%
Interest Expense1.65M1.54M266.00K3.00K31.00K17.00K233.00K5.13M4.19M2.68M6.40M7.47M8.07M6.46M8.22M5.67M7.79M
Interest Expense % of Total Revenue10.52%2.33%0.19%0.00%0.02%0.01%0.09%2.25%1.62%0.81%1.46%1.60%1.60%1.16%1.15%0.64%0.88%

Balance Sheet

Currency: TWD2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets188.40M222.97M403.87M483.28M1.13B1.09B1.07B1.36B1.56B1.70B1.86B1.89B2.26B2.10B2.16B2.35B2.67B
Total Liabilities104.31M111.24M40.17M57.31M45.23M68.81M124.16M462.93M648.72M617.70M501.08M486.55M812.06M587.30M533.66M457.43M689.35M
Total Equity84.09M111.73M363.70M425.98M1.08B1.02B948.60M894.21M914.45M1.08B1.36B1.40B1.45B1.51B1.63B1.90B1.98B
Cash906.00K27.00M79.80M117.75M666.58M366.49M201.37M334.20M330.09M368.95M331.05M397.36M658.92M587.02M511.10M706.02M845.81M
Total Debt37.51M17.07M2.25M5.59M4.56M1.08M27.10M312.86M500.49M437.91M313.31M323.68M635.37M416.05M347.91M224.24M485.13M
Net Debt36.60M-9.93M-77.55M-112.16M-662.02M-365.41M-174.27M-21.34M170.40M68.95M-17.74M-73.68M-23.55M-170.97M-163.19M-481.79M-360.67M

Cash Flow

Currency: TWD2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-36.09M6.85M37.13M51.52M37.27M1.85M49.81M38.29M15.98M111.70M204.40M126.47M98.51M178.21M272.01M269.87M123.99M
Investing Cash Flow-16.64M-23.19M-138.52M-13.57M-74.74M-267.26M-115.16M-164.07M-206.02M-84.48M-246.40M20.37M-77.00M49.59M-213.37M97.52M-142.74M
Financing Cash Flow-21.46M42.44M154.19M-607.80M-34.96M-99.34M258.44M187.01M11.68M4.18M-80.53M240.06M-299.71M-134.53M-172.52M158.53M
Capital Expenditure16.38M23.13M20.91M13.58M27.74M126.27M205.27M230.32M324.26M95.32M202.03M66.84M25.77M14.96M14.84M34.88M101.53M
Free Cash Flow-52.47M-16.28M16.21M37.94M9.54M-124.42M-155.46M-192.04M-308.28M16.38M2.37M59.63M72.73M163.24M257.17M234.99M22.46M
Dividends Paid-----35.00M25.80M25.80M10.32M10.32M92.96M79.26M58.56M93.83M133.30M169.33M233.87M
FCF to OCF145.40%-237.78%43.67%73.64%25.59%-6718.03%-312.13%-501.58%-1929.43%14.66%1.16%47.15%73.83%91.60%94.54%87.08%18.12%
Dividend Paid to FCF------28.13%-16.60%-13.43%-3.35%63.01%3930.66%132.92%80.51%57.48%51.83%72.06%1041.14%

Earnings

Report DateJun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Sep 3, 2014Dec 3, 2014Feb 25, 2015Jun 3, 2015Sep 2, 2015Dec 2, 2015Mar 2, 2016Jun 1, 2016Aug 31, 2016Nov 30, 2016Mar 29, 2017May 31, 2017Aug 30, 2017Nov 7, 2017Mar 28, 2018May 30, 2018Aug 29, 2018Nov 6, 2018Mar 28, 2019May 10, 2019Aug 8, 2019Nov 11, 2019Mar 25, 2020May 12, 2020Aug 6, 2020Nov 5, 2020May 6, 2021Aug 4, 2021Nov 4, 2021Mar 23, 2022May 12, 2022Aug 3, 2022Nov 3, 2022Mar 21, 2023May 10, 2023May 9, 2024Aug 8, 2024Nov 7, 2024Mar 6, 2025
EPS Estimate----------------------------------0.650.71-----------0.640.751.221.17
EPS Actual0.430.310.280.110.160.380.530.140.170.350.090.020.01-0.02-0.360.220.090.420.17-0.010.01-0.800.36-0.040.020.010.290.590.060.260.510.440.380.380.640.540.330.500.370.470.280.500.410.600.690.320.470.710.930.800.84
Surprise-----------------------------------1.54%-23.94%-----------10.94%24.00%-34.43%-28.21%
Timing------------------------------After-hoursPre-marketPre-marketPre-market-After-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap3.11B
Enterprise Value2.71B
Trailing P/E17.91
Forward P/E0.00
Price / Sales3.50
Price / Book1.75
EPS2.39
Book Value23.88
Revenue (TTM)889.15M
Gross Profit (TTM)627.69M
EBITDA222.90M
Profit Margin20.03%
Operating Margin13.61%
Return on Equity10.16%
Return on Assets3.89%
Shares Outstanding72.69M
Shares Float51.21M
Beta0.46
Dividend Yield4.41%
Dividend Rate1.91
Payout Ratio79.94%

Dividends

20231×
1.94Jul 26, 2023
20221×
1.42Jul 18, 2022
20211×
0.96Oct 4, 2021
20201×
1.26Sep 2, 2020
20191×
0.75Aug 12, 2019
20181×
0.17Jun 14, 2018
20161×
0.43Jul 7, 2016
20141×
0.60Aug 28, 2014

Stock Splits

  • Oct 4, 2021217:200
  • Sep 2, 202021:20
  • Jan 7, 2019797:781
  • Aug 28, 2014107:100
  • Aug 27, 201353:50
  • Jan 18, 2011600:587